PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of molmedLink to Publisher's site
 
Mol Med. 1998 September; 4(9): 557–591.
PMCID: PMC2230318

Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (5.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993 Dec 30;329(27):2002–2012. [PubMed]
  • Bredt DS, Snyder SH. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem. 1994;63:175–195. [PubMed]
  • Clancy RM, Abramson SB. Nitric oxide: a novel mediator of inflammation. Proc Soc Exp Biol Med. 1995 Nov;210(2):93–101. [PubMed]
  • Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem. 1994 May 13;269(19):13725–13728. [PubMed]
  • MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol. 1997;15:323–350. [PubMed]
  • Gross SS, Levi R. Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J Biol Chem. 1992 Dec 25;267(36):25722–25729. [PubMed]
  • Rosenkranz-Weiss P, Sessa WC, Milstien S, Kaufman S, Watson CA, Pober JS. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J Clin Invest. 1994 May;93(5):2236–2243. [PMC free article] [PubMed]
  • Nathan C. Nitric oxide and biopterin: a study in Chiaroscuro. J Clin Invest. 1994 May;93(5):1875–1876. [PMC free article] [PubMed]
  • Assreuy J, Cunha FQ, Liew FY, Moncada S. Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol. 1993 Mar;108(3):833–837. [PMC free article] [PubMed]
  • Rogers NE, Ignarro LJ. Constitutive nitric oxide synthase from cerebellum is reversibly inhibited by nitric oxide formed from L-arginine. Biochem Biophys Res Commun. 1992 Nov 30;189(1):242–249. [PubMed]
  • Albina JE. On the expression of nitric oxide synthase by human macrophages. Why no NO? J Leukoc Biol. 1995 Dec;58(6):643–649. [PubMed]
  • Denis M. Human monocytes/macrophages: NO or no NO? J Leukoc Biol. 1994 May;55(5):682–684. [PubMed]
  • Ochoa JB, Curti B, Peitzman AB, Simmons RL, Billiar TR, Hoffman R, Rault R, Longo DL, Urba WJ, Ochoa AC. Increased circulating nitrogen oxides after human tumor immunotherapy: correlation with toxic hemodynamic changes. J Natl Cancer Inst. 1992 Jun 3;84(11):864–867. [PubMed]
  • Hibbs JB, Jr, Westenfelder C, Taintor R, Vavrin Z, Kablitz C, Baranowski RL, Ward JH, Menlove RL, McMurry MP, Kushner JP, et al. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest. 1992 Mar;89(3):867–877. [PMC free article] [PubMed]
  • Green LC, Ruiz de Luzuriaga K, Wagner DA, Rand W, Istfan N, Young VR, Tannenbaum SR. Nitrate biosynthesis in man. Proc Natl Acad Sci U S A. 1981 Dec;78(12):7764–7768. [PubMed]
  • Kun JF, Mordmüller B, Lell B, Lehman LG, Luckner D, Kremsner PG. Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet. 1998 Jan 24;351(9098):265–266. [PubMed]
  • Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science. 1992 Dec 18;258(5090):1898–1902. [PubMed]
  • Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 1982 Oct;126(1):131–138. [PubMed]
  • Beckman JS, Chen J, Ischiropoulos H, Crow JP. Oxidative chemistry of peroxynitrite. Methods Enzymol. 1994;233:229–240. [PubMed]
  • Mannick JB, Asano K, Izumi K, Kieff E, Stamler JS. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell. 1994 Dec 30;79(7):1137–1146. [PubMed]
  • Mannick JB, Miao XQ, Stamler JS. Nitric oxide inhibits Fas-induced apoptosis. J Biol Chem. 1997 Sep 26;272(39):24125–24128. [PubMed]
  • Reiling N, Kröncke R, Ulmer AJ, Gerdes J, Flad HD, Hauschildt S. Nitric oxide synthase: expression of the endothelial, Ca2+/calmodulin-dependent isoform in human B and T lymphocytes. Eur J Immunol. 1996 Mar;26(3):511–516. [PubMed]
  • Chen LY, Mehta JL. Further evidence of the presence of constitutive and inducible nitric oxide synthase isoforms in human platelets. J Cardiovasc Pharmacol. 1996 Jan;27(1):154–158. [PubMed]
  • Radomski MW, Palmer RM, Moncada S. Characterization of the L-arginine:nitric oxide pathway in human platelets. Br J Pharmacol. 1990 Oct;101(2):325–328. [PMC free article] [PubMed]
  • Malinski T, Radomski MW, Taha Z, Moncada S. Direct electrochemical measurement of nitric oxide released from human platelets. Biochem Biophys Res Commun. 1993 Jul 30;194(2):960–965. [PubMed]
  • Weinberg JB, Misukonis MA, Shami PJ, Mason SN, Sauls DL, Dittman WA, Wood ER, Smith GK, McDonald B, Bachus KE, et al. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood. 1995 Aug 1;86(3):1184–1195. [PubMed]
  • Salvemini D, de Nucci G, Gryglewski RJ, Vane JR. Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor. Proc Natl Acad Sci U S A. 1989 Aug;86(16):6328–6332. [PubMed]
  • Hunt NC, Goldin RD. Nitric oxide production by monocytes in alcoholic liver disease. J Hepatol. 1992 Mar;14(2-3):146–150. [PubMed]
  • Middleton SJ, Cuthbert AW, Shorthouse M, Hunter JO. Nitric oxide affects mammalian distal colonic smooth muscle by tonic neural inhibition. Br J Pharmacol. 1993 Apr;108(4):974–979. [PMC free article] [PubMed]
  • Martin JH, Edwards SW. Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing. J Immunol. 1993 Apr 15;150(8 Pt 1):3478–3486. [PubMed]
  • Wickramasinghe SN, Hasan R. Possible role of macrophages in the pathogenesis of ethanol-induced bone marrow damage. Br J Haematol. 1993 Apr;83(4):574–579. [PubMed]
  • Petit JF, Phan-Bich L, Lemaire G, Martinache C, Lopez M. During their differentiation into macrophages, human monocytes acquire cytostatic activity independent of NO and TNF alpha. Res Immunol. 1993 May;144(4):277–298. [PubMed]
  • Chu SC, Wu HP, Banks TC, Eissa NT, Moss J. Structural diversity in the 5'-untranslated region of cytokine-stimulated human inducible nitric oxide synthase mRNA. J Biol Chem. 1995 May 5;270(18):10625–10630. [PubMed]
  • Eissa NT, Strauss AJ, Haggerty CM, Choo EK, Chu SC, Moss J. Alternative splicing of human inducible nitric-oxide synthase mRNA. tissue-specific regulation and induction by cytokines. J Biol Chem. 1996 Oct 25;271(43):27184–27187. [PubMed]
  • Granger DL, Hibbs JB, Jr, Perfect JR, Durack DT. Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. J Clin Invest. 1988 Apr;81(4):1129–1136. [PMC free article] [PubMed]
  • Cameron ML, Granger DL, Weinberg JB, Kozumbo WJ, Koren HS. Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate. Am Rev Respir Dis. 1990 Dec;142(6 Pt 1):1313–1319. [PubMed]
  • Denis M. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leukoc Biol. 1991 Apr;49(4):380–387. [PubMed]
  • Sherman MP, Loro ML, Wong VZ, Tashkin DP. Cytokine- and Pneumocystis carinii- induced L-arginine oxidation by murine and human pulmonary alveolar macrophages. J Protozool. 1991 Nov-Dec;38(6):234S–236S. [PubMed]
  • Muñoz-Fernández MA, Fernández MA, Fresno M. Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-alpha and IFN-gamma through a nitric oxide-dependent mechanism. Immunol Lett. 1992 Jun;33(1):35–40. [PubMed]
  • Harwix S, Andreesen R, Ferber E, Schwamberger G. Human macrophages secrete a tumoricidal activity distinct from tumour necrosis factor-alpha and reactive nitrogen intermediates. Res Immunol. 1992 Jan;143(1):89–94. [PubMed]
  • Murray HW, Teitelbaum RF. L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J Infect Dis. 1992 Mar;165(3):513–517. [PubMed]
  • Padgett EL, Pruett SB. Evaluation of nitrite production by human monocyte-derived macrophages. Biochem Biophys Res Commun. 1992 Jul 31;186(2):775–781. [PubMed]
  • Ben-Efraim S, Tak C, Fieren MJ, Romijn JC, Beckmann I, Bonta IL. Activity of human peritoneal macrophages against a human tumor: role of tumor necrosis factor-alpha, PGE2 and nitrite, in vitro studies. Immunol Lett. 1993 Jul;37(1):27–33. [PubMed]
  • Bermudez LE. Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages. The role of nitric oxide. Clin Exp Immunol. 1993 Feb;91(2):277–281. [PubMed]
  • Keller R, Keist R, Joller P, Groscurth P. Mononuclear phagocytes from human bone marrow progenitor cells; morphology, surface phenotype, and functional properties of resting and activated cells. Clin Exp Immunol. 1993 Jan;91(1):176–182. [PubMed]
  • Sakai N, Milstien S. Availability of tetrahydrobiopterin is not a factor in the inability to detect nitric oxide production by human macrophages. Biochem Biophys Res Commun. 1993 May 28;193(1):378–383. [PubMed]
  • Schneemann M, Schoedon G, Hofer S, Blau N, Guerrero L, Schaffner A. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis. 1993 Jun;167(6):1358–1363. [PubMed]
  • Barnewall RE, Rikihisa Y. Abrogation of gamma interferon-induced inhibition of Ehrlichia chaffeensis infection in human monocytes with iron-transferrin. Infect Immun. 1994 Nov;62(11):4804–4810. [PMC free article] [PubMed]
  • Essery SD, Saadi AT, Twite SJ, Weir DM, Blackwell CC, Busuttil A. Lewis antigen expression on human monocytes and binding of pyrogenic toxins. Agents Actions. 1994 Mar;41(1-2):108–110. [PubMed]
  • Gyan B, Troye-Blomberg M, Perlmann P, Björkman A. Human monocytes cultured with and without interferon-gamma inhibit Plasmodium falciparum parasite growth in vitro via secretion of reactive nitrogen intermediates. Parasite Immunol. 1994 Jul;16(7):371–375. [PubMed]
  • Leibovich SJ, Polverini PJ, Fong TW, Harlow LA, Koch AE. Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc Natl Acad Sci U S A. 1994 May 10;91(10):4190–4194. [PubMed]
  • Martin JH, Edwards SW. Interferon-gamma enhances monocyte cytotoxicity via enhanced reactive oxygen intermediate production. Absence of an effect on macrophage cytotoxicity is due to failure to enhance reactive nitrogen intermediate production. Immunology. 1994 Apr;81(4):592–597. [PubMed]
  • Zembala M, Siedlar M, Marcinkiewicz J, Pryjma J. Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolysaccharide. Eur J Immunol. 1994 Feb;24(2):435–439. [PubMed]
  • Siedlar M, Marcinkiewicz J, Zembala M. MHC class I and class II determinants and some adhesion molecules are engaged in the regulation of nitric oxide production in vitro by human monocytes stimulated with colon carcinoma cells. Clin Immunol Immunopathol. 1995 Dec;77(3):380–384. [PubMed]
  • Bose M, Farnia P. Proinflammatory cytokines can significantly induce human mononuclear phagocytes to produce nitric oxide by a cell maturation-dependent process. Immunol Lett. 1995 Nov;48(1):59–64. [PubMed]
  • Reiling N, Ulmer AJ, Duchrow M, Ernst M, Flad HD, Hauschildt S. Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur J Immunol. 1994 Aug;24(8):1941–1944. [PubMed]
  • Bukrinsky MI, Nottet HS, Schmidtmayerova H, Dubrovsky L, Flanagan CR, Mullins ME, Lipton SA, Gendelman HE. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med. 1995 Feb 1;181(2):735–745. [PMC free article] [PubMed]
  • Bagasra O, Bobroski L, Sarker A, Bagasra A, Saikumari P, Pomerantz RJ. Absence of the inducible form of nitric oxide synthase in the brains of patients with the acquired immunodeficiency syndrome. J Neurovirol. 1997 Apr;3(2):153–167. [PubMed]
  • Liu J, Zhao ML, Brosnan CF, Lee SC. Expression of type II nitric oxide synthase in primary human astrocytes and microglia: role of IL-1beta and IL-1 receptor antagonist. J Immunol. 1996 Oct 15;157(8):3569–3576. [PubMed]
  • Zinetti M, Fantuzzi G, Delgado R, Di Santo E, Ghezzi P, Fratelli M. Endogenous nitric oxide production by human monocytic cells regulates LPS-induced TNF production. Eur Cytokine Netw. 1995 Jan-Feb;6(1):45–48. [PubMed]
  • Condino-neto A, Muscará MN, Bellinati-Pires R, Carneiro-Sampaio MM, Brandão AC, Grumach AS, De Nucci G. Effect of therapy with recombinant human interferon-gamma on the release of nitric oxide by neutrophils and mononuclear cells from patients with chronic granulomatous disease. J Interferon Cytokine Res. 1996 May;16(5):357–364. [PubMed]
  • Kashem A, Endoh M, Yano N, Yamauchi F, Nomoto Y, Sakai H. Expression of inducible-NOS in human glomerulonephritis: the possible source is infiltrating monocytes/macrophages. Kidney Int. 1996 Aug;50(2):392–399. [PubMed]
  • St Clair EW, Wilkinson WE, Lang T, Sanders L, Misukonis MA, Gilkeson GS, Pisetsky DS, Granger DI, Weinberg JB. Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients. J Exp Med. 1996 Sep 1;184(3):1173–1178. [PMC free article] [PubMed]
  • Wang CL, Su MH, Chao TY, Shaio MF, Yang KD. When do human macrophages release nitric oxide? Variable effects of certain in vitro cultural and in vivo resident conditions. Proc Natl Sci Counc Repub China B. 1996 Jul;20(3):65–70. [PubMed]
  • Amin AR, Attur M, Vyas P, Leszczynska-Piziak J, Levartovsky D, Rediske J, Clancy RM, Vora KA, Abramson SB. Expression of nitric oxide synthase in human peripheral blood mononuclear cells and neutrophils. J Inflamm. 1995;47(4):190–205. [PubMed]
  • Polack B, Pernod G, Barro C, Doussière J. Role of oxygen radicals in tissue factor induction by endotoxin in blood monocytes. Haemostasis. 1997 Jul-Aug;27(4):193–200. [PubMed]
  • Saha DC, Astiz ME, Lin RY, Rackow EC, Eales LJ. Monophosphoryl lipid A stimulated up-regulation of nitric oxide synthase and nitric oxide release by human monocytes in vitro. Immunopharmacology. 1997 Oct;37(2-3):175–184. [PubMed]
  • Snell JC, Chernyshev O, Gilbert DL, Colton CA. Polyribonucleotides induce nitric oxide production by human monocyte-derived macrophages. J Leukoc Biol. 1997 Sep;62(3):369–373. [PubMed]
  • Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol. 1988 Oct 1;141(7):2407–2412. [PubMed]
  • Zhou A, Chen Z, Rummage JA, Jiang H, Kolosov M, Kolosova I, Stewart CA, Leu RW. Exogenous interferon-gamma induces endogenous synthesis of interferon-alpha and -beta by murine macrophages for induction of nitric oxide synthase. J Interferon Cytokine Res. 1995 Oct;15(10):897–904. [PubMed]
  • Diefenbach A, Schindler H, Donhauser N, Lorenz E, Laskay T, MacMicking J, Röllinghoff M, Gresser I, Bogdan C. Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity. 1998 Jan;8(1):77–87. [PubMed]
  • Sharara AI, Perkins DJ, Misukonis MA, Chan SU, Dominitz JA, Weinberg JB. Interferon (IFN)-alpha activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-alpha in vivo. J Exp Med. 1997 Nov 3;186(9):1495–1502. [PMC free article] [PubMed]
  • Kolb JP, Paul-Eugene N, Damais C, Yamaoka K, Drapier JC, Dugas B. Interleukin-4 stimulates cGMP production by IFN-gamma-activated human monocytes. Involvement of the nitric oxide synthase pathway. J Biol Chem. 1994 Apr 1;269(13):9811–9816. [PubMed]
  • Mautino G, Paul-Eugène N, Chanez P, Vignola AM, Kolb JP, Bousquet J, Dugas B. Heterogeneous spontaneous and interleukin-4-induced nitric oxide production by human monocytes. J Leukoc Biol. 1994 Jul;56(1):15–20. [PubMed]
  • Paul-Eugène N, Kolb JP, Damais C, Yamaoka K, Dugas B. Regulatory role of nitric oxide in the IL-4-induced IgE production by normal human peripheral blood mononuclear cells. Lymphokine Cytokine Res. 1994 Oct;13(5):287–293. [PubMed]
  • Lecoanet-Henchoz S, Gauchat JF, Aubry JP, Graber P, Life P, Paul-Eugene N, Ferrua B, Corbi AL, Dugas B, Plater-Zyberk C, et al. CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18. Immunity. 1995 Jul;3(1):119–125. [PubMed]
  • Paul-Eugène N, Kolb JP, Sarfati M, Arock M, Ouaaz F, Debré P, Mossalayi DM, Dugas B. Ligation of CD23 activates soluble guanylate cyclase in human monocytes via an L-arginine-dependent mechanism. J Leukoc Biol. 1995 Jan;57(1):160–167. [PubMed]
  • Paul-Eugène N, Pène J, Bousquet J, Dugas B. Role of cyclic nucleotides and nitric oxide in blood mononuclear cell IgE production stimulated by IL-4. Cytokine. 1995 Jan;7(1):64–69. [PubMed]
  • Paul-Eugène N, Mossalayi D, Sarfati M, Yamaoka K, Aubry JP, Bonnefoy JY, Dugas B, Kolb JP. Evidence for a role of Fc epsilon RII/CD23 in the IL-4-induced nitric oxide production by normal human mononuclear phagocytes. Cell Immunol. 1995 Jul;163(2):314–318. [PubMed]
  • Dugas N, Vouldoukis I, Bécherel P, Arock M, Debré P, Tardieu M, Mossalayi DM, Delfraissy JF, Kolb JP, Dugas B. Triggering of CD23b antigen by anti-CD23 monoclonal antibodies induces interleukin-10 production by human macrophages. Eur J Immunol. 1996 Jun;26(6):1394–1398. [PubMed]
  • Vouldoukis I, Riveros-Moreno V, Dugas B, Ouaaz F, Bécherel P, Debré P, Moncada S, Mossalayi MD. The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen. Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7804–7808. [PubMed]
  • Aubry JP, Dugas N, Lecoanet-Henchoz S, Ouaaz F, Zhao H, Delfraissy JF, Graber P, Kolb JP, Dugas B, Bonnefoy JY. The 25-kDa soluble CD23 activates type III constitutive nitric oxide-synthase activity via CD11b and CD11c expressed by human monocytes. J Immunol. 1997 Jul 15;159(2):614–622. [PubMed]
  • Vouldoukis I, Bécherel PA, Riveros-Moreno V, Arock M, da Silva O, Debré P, Mazier D, Mossalayi MD. Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation. Eur J Immunol. 1997 Apr;27(4):860–865. [PubMed]
  • Schneemann M, Schoedon G, Linscheid P, Walter R, Blau N, Schaffner A. Nitrite generation in interleukin-4-treated human macrophage cultures does not involve the nitric oxide synthase pathway. J Infect Dis. 1997 Jan;175(1):130–135. [PubMed]
  • Dumarey CH, Labrousse V, Rastogi N, Vargaftig BB, Bachelet M. Selective Mycobacterium avium-induced production of nitric oxide by human monocyte-derived macrophages. J Leukoc Biol. 1994 Jul;56(1):36–40. [PubMed]
  • Naotunne TS, Karunaweera ND, Mendis KN, Carter R. Cytokine-mediated inactivation of malarial gametocytes is dependent on the presence of white blood cells and involves reactive nitrogen intermediates. Immunology. 1993 Apr;78(4):555–562. [PubMed]
  • Seitzer U, Scheel-Toellner D, Toellner KM, Reiling N, Haas H, Galle J, Flad HD, Gerdes J. Properties of multinucleated giant cells in a new in vitro model for human granuloma formation. J Pathol. 1997 May;182(1):99–105. [PubMed]
  • Pietraforte D, Tritarelli E, Testa U, Minetti M. gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages. J Leukoc Biol. 1994 Feb;55(2):175–182. [PubMed]
  • Tufano MA, Rossano F, Catalanotti P, Liguori G, Marinelli A, Baroni A, Marinelli P. Properties of Yersinia enterocolitica porins: interference with biological functions of phagocytes, nitric oxide production and selective cytokine release. Res Microbiol. 1994 May;145(4):297–307. [PubMed]
  • Belenky SN, Robbins RA, Rubinstein I. Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro. J Leukoc Biol. 1993 May;53(5):498–503. [PubMed]
  • De Maria R, Cifone MG, Trotta R, Rippo MR, Festuccia C, Santoni A, Testi R. Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J Exp Med. 1994 Nov 1;180(5):1999–2004. [PMC free article] [PubMed]
  • Pérez-Mediavilla LA, López-Zabalza MJ, Calonge M, Montuenga L, López-Moratalla N, Santiago E. Inducible nitric oxide synthase in human lymphomononuclear cells activated by synthetic peptides derived from extracellular matrix proteins. FEBS Lett. 1995 Jan 3;357(2):121–124. [PubMed]
  • McLachlan JA, Serkin CD, Bakouche O. Dehydroepiandrosterone modulation of lipopolysaccharide-stimulated monocyte cytotoxicity. J Immunol. 1996 Jan 1;156(1):328–335. [PubMed]
  • Magazine HI, Liu Y, Bilfinger TV, Fricchione GL, Stefano GB. Morphine-induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide. J Immunol. 1996 Jun 15;156(12):4845–4850. [PubMed]
  • Aymerich MS, Bengoechea-Alonso MT, López-Zabalza MJ, Santiago E, López-Moratalla N. Inducible nitric oxide synthase (iNOS) expression in human monocytes triggered by beta-endorphin through an increase in cAMP. Biochem Biophys Res Commun. 1998 Apr 28;245(3):717–721. [PubMed]
  • Stefano GB, Liu Y, Goligorsky MS. Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes. J Biol Chem. 1996 Aug 9;271(32):19238–19242. [PubMed]
  • King JM, Srivastava KD, Stefano GB, Bilfinger TV, Bahou WF, Magazine HI. Human monocyte adhesion is modulated by endothelin B receptor-coupled nitric oxide release. J Immunol. 1997 Jan 15;158(2):880–886. [PubMed]
  • Lammas DA, Stober C, Harvey CJ, Kendrick N, Panchalingam S, Kumararatne DS. ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity. 1997 Sep;7(3):433–444. [PubMed]
  • Vitek MP, Snell J, Dawson H, Colton CA. Modulation of nitric oxide production in human macrophages by apolipoprotein-E and amyloid-beta peptide. Biochem Biophys Res Commun. 1997 Nov 17;240(2):391–394. [PubMed]
  • Criado-Jiménez M, Rivas-Cabañero L, Martín-Oterino JA, López-Novoa JM, Sánchez-Rodríguez A. Nitric oxide production by mononuclear leukocytes in alcoholic cirrhosis. J Mol Med (Berl) 1995 Jan;73(1):31–33. [PubMed]
  • Laffi G, Foschi M, Masini E, Simoni A, Mugnai L, La Villa G, Barletta G, Mannaioni PF, Gentilini P. Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. Hepatology. 1995 Dec;22(6):1666–1673. [PubMed]
  • Masini E, Mugnai L, Foschi M, Laffi G, Gentilini P, Mannaioni PF. Changes in the production of nitric oxide and superoxide by inflammatory cells in liver cirrhosis. Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):197–198. [PubMed]
  • Majano PL, García-Monzón C, López-Cabrera M, Lara-Pezzi E, Fernández-Ruiz E, García-Iglesias C, Borque MJ, Moreno-Otero R. Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation. J Clin Invest. 1998 Apr 1;101(7):1343–1352. [PMC free article] [PubMed]
  • Kobzik L, Bredt DS, Lowenstein CJ, Drazen J, Gaston B, Sugarbaker D, Stamler JS. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol. 1993 Oct;9(4):371–377. [PubMed]
  • Tracey WR, Xue C, Klinghofer V, Barlow J, Pollock JS, Förstermann U, Johns RA. Immunochemical detection of inducible NO synthase in human lung. Am J Physiol. 1994 Jun;266(6 Pt 1):L722–L727. [PubMed]
  • Haddad IY, Pataki G, Hu P, Galliani C, Beckman JS, Matalon S. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest. 1994 Dec;94(6):2407–2413. [PMC free article] [PubMed]
  • Kooy NW, Royall JA, Ye YZ, Kelly DR, Beckman JS. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med. 1995 Apr;151(4):1250–1254. [PubMed]
  • McDermott CD, Gavita SM, Shennib H, Giaid A. Immunohistochemical localization of nitric oxide synthase and the oxidant peroxynitrite in lung transplant recipients with obliterative bronchiolitis. Transplantation. 1997 Jul 27;64(2):270–274. [PubMed]
  • Nozaki Y, Hasegawa Y, Ichiyama S, Nakashima I, Shimokata K. Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages. Infect Immun. 1997 Sep;65(9):3644–3647. [PMC free article] [PubMed]
  • Kumar V, Jindal SK, Ganguly NK. Release of reactive oxygen and nitrogen intermediates from monocytes of patients with pulmonary tuberculosis. Scand J Clin Lab Invest. 1995 Apr;55(2):163–169. [PubMed]
  • Nicholson S, Bonecini-Almeida M da G, Lapa e Silva JR, Nathan C, Xie QW, Mumford R, Weidner JR, Calaycay J, Geng J, Boechat N, et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med. 1996 May 1;183(5):2293–2302. [PMC free article] [PubMed]
  • Tunçtan B, Okur H, Calişir CH, Abacioğlu H, Cakici I, Kanzik I, Abacioğlu N. Comparison of nitric oxide production by monocyte/macrophages in healthy subjects and patients with active pulmonary tuberculosis. Pharmacol Res. 1998 Mar;37(3):219–226. [PubMed]
  • Wang CH, Liu CY, Lin HC, Yu CT, Chung KF, Kuo HP. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur Respir J. 1998 Apr;11(4):809–815. [PubMed]
  • Beckmann JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White CR. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler. 1994 Feb;375(2):81–88. [PubMed]
  • Buttery LD, Springall DR, Chester AH, Evans TJ, Standfield EN, Parums DV, Yacoub MH, Polak JM. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest. 1996 Jul;75(1):77–85. [PubMed]
  • Wilcox JN, Subramanian RR, Sundell CL, Tracey WR, Pollock JS, Harrison DG, Marsden PA. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2479–2488. [PubMed]
  • Luoma JS, Strålin P, Marklund SL, Hiltunen TP, Särkioja T, Ylä-Herttuala S. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler Thromb Vasc Biol. 1998 Feb;18(2):157–167. [PubMed]
  • Lafond-Walker A, Chen CL, Augustine S, Wu TC, Hruban RH, Lowenstein CJ. Inducible nitric oxide synthase expression in coronary arteries of transplanted human hearts with accelerated graft arteriosclerosis. Am J Pathol. 1997 Oct;151(4):919–925. [PubMed]
  • Wildhirt SM, Dudek RR, Suzuki H, Bing RJ. Involvement of inducible nitric oxide synthase in the inflammatory process of myocardial infarction. Int J Cardiol. 1995 Jul;50(3):253–261. [PubMed]
  • Weyand CM, Wagner AD, Björnsson J, Goronzy JJ. Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis. J Clin Invest. 1996 Oct 1;98(7):1642–1649. [PMC free article] [PubMed]
  • Sakurai H, Kohsaka H, Liu MF, Higashiyama H, Hirata Y, Kanno K, Saito I, Miyasaka N. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest. 1995 Nov;96(5):2357–2363. [PMC free article] [PubMed]
  • McInnes IB, Leung BP, Field M, Wei XQ, Huang FP, Sturrock RD, Kinninmonth A, Weidner J, Mumford R, Liew FY. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med. 1996 Oct 1;184(4):1519–1524. [PMC free article] [PubMed]
  • Grabowski PS, Wright PK, Van 't Hof RJ, Helfrich MH, Ohshima H, Ralston SH. Immunolocalization of inducible nitric oxide synthase in synovium and cartilage in rheumatoid arthritis and osteoarthritis. Br J Rheumatol. 1997 Jun;36(6):651–655. [PubMed]
  • Moilanen E, Moilanen T, Knowles R, Charles I, Kadoya Y, al-Saffar N, Revell PA, Moncada S. Nitric oxide synthase is expressed in human macrophages during foreign body inflammation. Am J Pathol. 1997 Mar;150(3):881–887. [PubMed]
  • Watkins SC, Macaulay W, Turner D, Kang R, Rubash HE, Evans CH. Identification of inducible nitric oxide synthase in human macrophages surrounding loosened hip prostheses. Am J Pathol. 1997 Apr;150(4):1199–1206. [PubMed]
  • Ambs S, Merriam WG, Bennett WP, Felley-Bosco E, Ogunfusika MO, Oser SM, Klein S, Shields PG, Billiar TR, Harris CC. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res. 1998 Jan 15;58(2):334–341. [PubMed]
  • Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V, Moncada S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res. 1994 Mar 1;54(5):1352–1354. [PubMed]
  • Cobbs CS, Brenman JE, Aldape KD, Bredt DS, Israel MA. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res. 1995 Feb 15;55(4):727–730. [PubMed]
  • Anstey NM, Weinberg JB, Hassanali MY, Mwaikambo ED, Manyenga D, Misukonis MA, Arnelle DR, Hollis D, McDonald MI, Granger DL. Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med. 1996 Aug 1;184(2):557–567. [PMC free article] [PubMed]
  • Furusu A, Miyazaki M, Abe K, Tsukasaki S, Shioshita K, Sasaki O, Miyazaki K, Ozono Y, Koji T, Harada T, et al. Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis. Kidney Int. 1998 Jun;53(6):1760–1768. [PubMed]
  • Singer II, Kawka DW, Scott S, Weidner JR, Mumford RA, Riehl TE, Stenson WF. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology. 1996 Oct;111(4):871–885. [PubMed]
  • Ikeda I, Kasajima T, Ishiyama S, Shimojo T, Takeo Y, Nishikawa T, Kameoka S, Hiroe M, Mitsunaga A. Distribution of inducible nitric oxide synthase in ulcerative colitis. Am J Gastroenterol. 1997 Aug;92(8):1339–1341. [PubMed]
  • Mannick EE, Bravo LE, Zarama G, Realpe JL, Zhang XJ, Ruiz B, Fontham ET, Mera R, Miller MJ, Correa P. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res. 1996 Jul 15;56(14):3238–3243. [PubMed]
  • ter Steege J, Buurman W, Arends JW, Forget P. Presence of inducible nitric oxide synthase, nitrotyrosine, CD68, and CD14 in the small intestine in celiac disease. Lab Invest. 1997 Jul;77(1):29–36. [PubMed]
  • Bö L, Dawson TM, Wesselingh S, Mörk S, Choi S, Kong PA, Hanley D, Trapp BD. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol. 1994 Nov;36(5):778–786. [PubMed]
  • Bagasra O, Michaels FH, Zheng YM, Bobroski LE, Spitsin SV, Fu ZF, Tawadros R, Koprowski H. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12041–12045. [PubMed]
  • De Groot CJ, Ruuls SR, Theeuwes JW, Dijkstra CD, Van der Valk P. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J Neuropathol Exp Neurol. 1997 Jan;56(1):10–20. [PubMed]
  • Hooper DC, Bagasra O, Marini JC, Zborek A, Ohnishi ST, Kean R, Champion JM, Sarker AB, Bobroski L, Farber JL, et al. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2528–2533. [PubMed]
  • Myatt L, Eis AL, Brockman DE, Kossenjans W, Greer I, Lyall F. Inducible (type II) nitric oxide synthase in human placental villous tissue of normotensive, pre-eclamptic and intrauterine growth-restricted pregnancies. Placenta. 1997 May;18(4):261–268. [PubMed]
  • Zarlingo TJ, Eis AL, Brockman DE, Kossenjans W, Myatt L. Comparative localization of endothelial and inducible nitric oxide synthase isoforms in haemochorial and epitheliochorial placentae. Placenta. 1997 Sep;18(7):511–520. [PubMed]
  • Eis AL, Brockman DE, Myatt L. Immunolocalization of the inducible nitric oxide synthase isoform in human fetal membranes. Am J Reprod Immunol. 1997 Oct;38(4):289–294. [PubMed]
  • Condino-Neto A, Muscará MN, Grumach AS, Carneiro-Sampaio MM, De Nucci G. Neutrophils and mononuclear cells from patients with chronic granulomatous disease release nitric oxide. Br J Clin Pharmacol. 1993 May;35(5):485–490. [PMC free article] [PubMed]
  • López-Moratalla N, Calleja A, González A, Pérez-Mediavilla LA, Aymerich MS, Burrel MA, Santiago E. Inducible nitric oxide synthase in monocytes from patients with Graves' disease. Biochem Biophys Res Commun. 1996 Sep 24;226(3):723–729. [PubMed]
  • Kim C, Schinkel C, Fuchs D, Stadler J, Walz A, Zedler S, von Donnersmarck GH, Faist E. Interleukin-13 effectively down-regulates the monocyte inflammatory potential during traumatic stress. Arch Surg. 1995 Dec;130(12):1330–1336. [PubMed]
  • Dias-Da-Motta P, Arruda VR, Muscará MN, Saad ST, De Nucci G, Costa FF, Condino-Neto A. The release of nitric oxide and superoxide anion by neutrophils and mononuclear cells from patients with sickle cell anaemia. Br J Haematol. 1996 May;93(2):333–340. [PubMed]

Articles from Molecular Medicine are provided here courtesy of The Feinstein Institute for Medical Research at North Shore LIJ